Literature DB >> 30268041

Autoimmune encephalitis with elevated N-type calcium channel antibodies as a multiple sclerosis mimic.

Jessica Frey1, Ann Murray2.   

Abstract

BACKGROUND: Voltage gated calcium channels (VGCC) are well-known targets for antibody-associated disease. Of the 5 VGCC subtypes, the most well-known is the P/Q subtype associated with Lambert-Eaton Myasthenic Syndrome (LEMS). However, this case focuses on the much less understood N-type calcium channel antibody. The objective of this case is to review the literature regarding the clinical significance of the N-type calcium channel antibody and its relationship to MS.
METHODS: A 37-year old male presented with vertigo, paranoia, and tremor and had MRI changes suggestive of demyelinating disease. Evaluation revealed positive N-type calcium channel antibodies. Steroids dramatically improved symptoms and normalized antibodies. Years later recurrent symptoms were again associated with elevated antibodies. RESULTS AND
CONCLUSION: This patient likely has autoimmune encephalitis associated with elevated N-type calcium channel antibodies. This case highlights the clinical significance of N-type calcium channel antibodies and the importance of correctly diagnosing patients with antibody mediated disease that may very well mimic more common neurologic diseases such as multiple sclerosis (MS).
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune encephalitis; Demyelination; Ion channels; Multiple sclerosis; Paraneoplastic; T2 Lesions

Mesh:

Substances:

Year:  2018        PMID: 30268041     DOI: 10.1016/j.msard.2018.09.028

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  1 in total

1.  Rapidly progressive dementia-associated N-type voltage-gated calcium channel antibody encephalopathy.

Authors:  Smathorn Thakolwiboon; Amputch Karukote; Gyeongmo Sohn; Walter R Duarte-Celada; Parunyou Julayanont
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.